MICHAEL GREEN: Open Payments
NPI 1205356003 · DOWNERS GROVE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$414 in 20 payments from 10 companies in 2025. Trend: 2023 $762 · 2024 $481 · 2025 $414
Food & beverage: $414
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $103 |
| Novartis Pharmaceuticals Corporation | 3 | $67 |
| GlaxoSmithKline, LLC. | 3 | $65 |
| SCPHARMACEUTICALS INC. | 2 | $53 |
| Novo Nordisk Inc | 1 | $29 |
| CVRx, Inc. | 1 | $28 |
| Merck Sharp & Dohme LLC | 1 | $27 |
| PFIZER INC. | 1 | $19 |
| Cranial Technologies, Inc | 1 | $17 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $7 |
Products named: REPATHA, LEQVIO, FUROSCIX, SHINGRIX, Wegovy, Barostim Neo System, VERQUVO, ELIQUIS.
Industry payments across IL — which companies pay providers there.
